News

Oxford University Covid-19 vaccine shows strong immune response in adults

Mid-stage tests for the Oxford University-AstraZeneca coronavirus vaccine show 'encouraging' results

The Oxford University coronavirus vaccine has shown a strong immune response in older adults, the most at-risk age group for Covid-19.

In mid-stage trial results published in the medical journal Lancet, researchers say the results for adults in their 60s and 70s are “encouraging”.

WSJ Logo
Ray Dalio Sells Last Stake in Bridgewater, the Hedge Fund That Made Him a BillionaireExternal link

Ray Dalio Sells Last Stake in Bridgewater, the Hedge Fund That Made Him a Billionaire